Attention Deficit/Hyperactivity Disorder
Conditions
Interventions
Sponsors
Research Center for Child Mental Development,Department of Cognitive Behavioral Physiology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who meet the diagnostic criteria in the DSM5. (2) Male or Female, aged 11-17 years (3) Patients who have been informed of the name of the disorder Persons who have been informed of the name of their disease at the time of obtaining consent (4) Patients are willing and able to give informed consent/informed assent for participation in the study. (5) Able to communicate fluently and participate cognitive behavioral therapy sessions in Japanese (6) Able to use the Internet and computer (7) Patients who have been stabilized on medications for ADHD (8) Parent is also able to participate in cognitive behavioral therapy sessions
Exclusion criteria
Exclusion criteria: (1) Diagnosis of schizophrenia, conduct disorders, organic disorder, mental retardation, autistic spectrum disorder, or substance abuse/substance dependence disorder (2) Active suicidal ideation (3) Unable to communicate fluently in Japanese. (4) Patients who have received cognitive behavioral therapy in the past (5) Other reasons inadequate for study participation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the ADHD-RS-IV Japanese Version | — |
Secondary
| Measure | Time frame |
|---|---|
| ADHD Symptoms Checklist Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD-7) Euro Qol 5 Dimension 5 level (EQ-5D-5L) Rosenberg's Self-esteem Scale | — |
Countries
Japan
Contacts
Public ContactAyumu Endo
Graduate School of Medicine Chiba University Department of Cognitive Behavioral Physiology
Outcome results
None listed